Study of treatment for recurrent retroperitoneal liposarcoma
Part of Cancer clinical trials.
This study looks at how well standard treatments work for people whose liposarcoma has come back in the same area. It helps doctors understand best ways to manage this rare cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your liposarcoma has come back for the first time in the belly or pelvis area
- You had surgery before that removed all visible cancer
- The cancer has not spread to other parts of your body on recent scans
- Doctors believe the tumor can be removed again with surgery and possibly radiation
- You are generally well enough to be up and about at least half of the day
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at genetic risk factors in people with retroperitoneal liposarcoma who are having surgery to remove the tumor. The goal is to understand how genes affect the disease and possibly guide future treatments.
This trial studies whether adding chemotherapy before surgery helps people with high-risk retroperitoneal (abdominal-area) leiomyosarcoma or liposarcoma. The goal is to improve outcomes while comparing surgery alone versus surgery plus neoadjuvant chemotherapy.
This trial tests a personalized treatment plan for children and young adults with a type of soft tissue sarcoma (NRSTS). It uses a combination of surgery, targeted radiation, and two drugs (pazopanib and selinexor) to fight cancer while reducing side effects. The study is looking for people who have not been treated before for this sarcoma.
This trial tests a first-line treatment for people with advanced or unresectable dedifferentiated liposarcoma that has spread. The goal is to find a therapy that works before other treatments are used.
This trial tests two experimental drugs (pemigatinib and retifanlimab) for advanced dedifferentiated liposarcoma that has not responded to other treatments. It aims to see if this combination can shrink tumors or slow cancer growth.
This study follows adults who have had surgery for a retroperitoneal sarcoma. It collects clinical and imaging information after treatment to better understand outcomes and guide future care.
Hear when a new Retroperitoneal Liposarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.